Berberine (hemisulfate)

Berberine hemisulfate is the hemisulfate form of Berberine (HY-N0716). Berberine hemisulfate is an alkaloid isolated from the Chinese herbal medicine Huanglian. Berberine hemisulfate exhibits anti-inflammatory, antibiobic, antitumor, cardiovascular protective and neuroprotective activity[1][2][3][4][5][6].

[1]Cai Y, et al. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J Nat Med. 2014 Jan;68(1):53-62.|[2]Cui HX, et al. Preparation and Evaluation of Antidiabetic Agents of Berberine Organic Acid Salts for Enhancing the Bioavailability. Molecules. 2018 Dec 28;24(1):103.|[3]Boberek JM, et al., Genetic evidence for inhibition of bacterial division protein FtsZ by berberine. PLoS One. 2010 Oct 29;5(10):e13745. |[4]Remppis A, et al., Rhizoma Coptidis inhibits LPS-induced MCP-1/CCL2 production in murine macrophages via an AP-1 and NFkappaB-dependent pathway. Mediators Inflamm. 2010;2010:194896.|[5]Bae J, et al., Berberine protects 6-hydroxydopamine-induced human dopaminergic neuronal cell death through the induction of heme oxygenase-1. Mol Cells. 2013 Feb;35(2):151-7. |[6]Ye Y, et al., Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Pharmacol. 2021 Apr 26;12:653887.Phytomedicine. 2024 Sep 30:135:156111.|Acta Pharmacol Sin. 2022 Aug 10.|Appl Biochem Biotechnol. 2023 Dec 28.|Aquaculture. 15 May 2022, 738055.|Biol Pharm Bull. 2022 Jul 20.|Biomed Pharmacother. 2023 Dec 18:170:116012.|BMC Pharmacol Toxicol. 2023 May 11;24(1):29.|Evid-Based Compl Alt. 2021 May 4.|Exp Cell Res. 2020 Aug 1;393(1):112054.|Exp Cell Res. 2024 May 13:114094.|Fish Shellfish Immunol. 2024 Mar 26:109522.|Food Chem Toxicol. 2023 Mar 25;113743.|Gene. 2022 Jan 10;146171.|Hepatol Commun. 2024 Mar 29;8(4):e0405.|Int J Nanomedicine. 2023 Jul 31.|J Bone Miner Metab. 2021 Apr 8.|J Ethnopharmacol. 2024 Apr 24:324:117829.|J Ethnopharmacol. 8 November 2021, 114786.|J Pharm Pharmacol. 2022 May 31;rgac026.|JCI Insight. 2023 Jul 24;8(14):e166306.|Mol Med Rep. 2023 Jan;27(1):17.|Pharm Biol. 2024 Dec;62(1):53-61.|Phytomedicine. 2023 Dec 2, 155247.|Research Square Preprint. 2021 Jun.|Research Square Preprint. 2021 Sep.|Sci Rep. 2022 Oct 17;12(1):17350.|SSRN. 2023 Jan 27.|Aquacult Nutr. 14 Jul 2022.|Biochem Pharmacol. 2021 Apr 27;114576.|Front Pharmacol. 2023 Apr 18:14:1148611.|Inflammopharmacology. 2024 May 17.|Int Immunopharmacol. 2024 May 29:136:112278.|Int Immunopharmacol. 2024 Sep 24;142(Pt B):113227.|J Appl Toxicol. 2024 Jul 9.|Mech Ageing Dev. 2020 Oct;191:111347.|Molecules. 2024 May 14.|Oncologie. 2023 Mar 10.|Phytomedicine. 2023 Jul 17, 154962.|Research Square Preprint. 2021 May.|Research Square Print. 2022 Aug.|Cardiovasc Drugs Ther. 2021 Jul 28.|J Appl Microbiol. 2021 Apr;130(4):1154-1172.|Microbiol Spectr. 2023 Sep 25;e0217023.|Int Immunopharmacol. 2024 Apr 18:133:112036.|Mol Reprod Dev. 2024 Aug;91(8):e23768.